We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Symptoms Prevalent Following Bariatric Surgery

By HospiMedica International staff writers
Posted on 20 Jan 2016
A new study reveals that the prevalence of symptoms such as abdominal pain and fatigue are high after Roux-en-Y gastric bypass (RYGB) surgery, with nearly one-third of patients admitted to hospital.

Researchers at Aarhus University Hospital (Denmark) surveyed 2,238 patients who underwent RYGB surgery between January 1, 2006, and December 31, 2011, in the central Denmark region to examine overall well-being and the prevalence and predictors of medical, nutritional, and surgical symptoms after RYGB surgery, and their association with quality of life. More...
The 1,429 (63.7%) patients who responded to the survey were compared to a control cohort of 89 individuals matched according to sex and body mass index (BMI), but who did not undergo RYGB surgery.

The results showed that 87.4% of the patients reported that their well-being was improved following surgery, with 88.6% reporting symptoms; 67.6% of the patients contacted the health care system about their symptoms, and 29.1% were hospitalized. The symptoms most commonly reported were abdominal pain (34%), fatigue (34%), anemia (28%), and gallstones (16%). Risk of symptoms was higher among women, patients younger than 35 years, smokers, the unemployed, and in those with surgical symptoms before RYGB surgery. The study was published online on January 6, 2016, in JAMA Surgery.

“Most patients reported improved well-being after RYGB surgery, but the prevalence of symptoms was high and nearly one-third of patients were hospitalized, 4- to 5-fold more than among the comparison group,” concluded lead author Sigrid Bjerge Gribsholt, MD, and colleagues. “Predictors of symptoms included young age, female sex, smoking, and experiencing symptoms before RYGB surgery. Development of weight loss procedures with fewer subsequent symptoms should be a high priority.”

For patients with morbid obesity, bariatric surgery (including RYGB surgery) is an effective treatment for weight loss and associated diseases. Various medical, nutritional, and surgical symptoms that require treatment may occur after RYGB surgery and may impair patients' quality of life.

Related Links:

Aarhus University Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.